Thursday 21 May 2026

One To Watch

Sapreme Technologies

A biotech company developing next-generation RNA therapeutics for patients with genetically driven diseases.

Company Overview

Want to Update your Company's Profile?


Latest Sapreme Technologies News

Former Byondis CEO gets top Sapreme job
28 May 2024
More Sapreme Technologies news >


Today's issue

MHRA proposes new framework to accelerate rare disease therapies in UK
Pharmaceutical
MHRA proposes new framework to accelerate rare disease therapies in UK
21 May 2026
Biotechnology
Scene set for Scenic to take ‘top-notch science’ into the clinic
20 May 2026
Pharmaceutical
US State price-setting boards create more questions than answers
20 May 2026
Pharmaceutical
Chiesi appoints Maria Paola Chiesi as first female chair
20 May 2026
Biotechnology
UK launches national framework to strengthen advanced therapy clinical trials
20 May 2026
Pharmaceutical
Remepy posts strong Phase IIa results for Hybridopa
20 May 2026
Pharmaceutical
Pfizer advances pediatric pneumococcal vaccine program
20 May 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze